Douglas Carr serves as Executive at Century Therapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Douglas Carr has executed 15 insider transactions totaling $7.5K, demonstrating a bearish approach to their equity position. Their most recent transaction on Feb 3, 2026 involved selling 323 shares valued at $589.
Douglas Carr currently holds 514,551 shares of Century Therapeutics, Inc. (IPSC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Douglas Carr has been a net seller of IPSC stock. They have purchased $0 and sold $7.5K worth of shares.
Douglas Carr's most recent insider trade was on Feb 3, 2026, when they sold 323 shares at $1.82 per share.
Get notified when new Form 4 filings are submitted
| $0.53 |
| Discretionary |
| Nov 3, 2025 | IPSC | $172 | Sale | 292 | $0.59 | Discretionary |
| Sep 8, 2025 | IPSC | $132 | Sale | 263 | $0.50 | Discretionary |
| Aug 4, 2025 | IPSC | $157 | Sale | 296 | $0.53 | Discretionary |
| Aug 5, 2024 | IPSC | $529 | Sale | 289 | $1.83 | Discretionary |
| Jun 7, 2024 | IPSC | $0 | Award | 17,007 | $N/A | Discretionary |
| May 3, 2024 | IPSC | $799 | Sale | 257 | $3.11 | Discretionary |
| Mar 7, 2024 | IPSC | $0 | Award | 14,000 | $N/A | Discretionary |
| Feb 6, 2024 | IPSC | $2.5K | Sale | 557 | $4.49 | Discretionary |
| Feb 5, 2024 | IPSC | $2.5K | Sale | 643 | $3.84 | Discretionary |
| Nov 1, 2023 | IPSC | $24.8K | Payment | 16,611 | $1.49 | Discretionary |
| May 15, 2023 | IPSC | $0 | Award | 120,846 | $N/A | Discretionary |
| Feb 2, 2023 | IPSC | $0 | Award | 7,500 | $N/A | Discretionary |
| Feb 2, 2023 | IPSC | $0 | Award | 7,500 | $N/A | Discretionary |